Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.
about
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-AnalysisPharmacologic therapy for New York Heart Association class IV heart failure.Pharmacological treatment of acute heart failure: current treatment and new targets.Editor's Choice- Call to action: Initiation of multidisciplinary care for acute heart failure begins in the Emergency Department.Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East.The Real Role of β-Blockers in Daily Cardiovascular Therapy.Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.Beta-adrenergic antagonists improve oxygen saturation in acute pulmonary edema: a case series in the prehospital setting.Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.The inodilator levosimendan as a treatment for acute heart failure in various settings.Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications.Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.[Acute and chronic heart failure in light of the new ESC guidelines].
P2860
Q26801321-BF7FEB0E-368C-4E81-8D39-D174CC02A23DQ37929864-B67A7458-3BF5-4486-B57E-12B505F7CED5Q38122297-5E18CAC1-682A-4E07-8A93-E53B0A210CB9Q38437103-60459B68-3B65-4C88-9D55-286586503D09Q38685401-206B1032-2054-469E-BB44-FAEF75C744CFQ39208428-BB0DC9A6-B866-44E1-AF6C-D2ED849398A3Q40478267-3C4CA9C8-CF12-44F7-AB03-C44B4E859809Q40666750-E2DC1A4F-4A18-4DDF-A0BD-875593A6E28EQ44604129-4C630D45-89E0-47DF-B37C-59345ED0173BQ46738415-8C89C027-1A39-476B-96B3-E1135F3AC77FQ47097922-1051FA6E-386D-4802-95A6-86A4242E14DAQ47696462-6BD2A1EA-E6E7-41F4-B5B5-A75B70F0F1CCQ51756509-A075551C-3253-4A13-ACF8-C1D8D48CA3B7Q53098624-1D163F1C-8678-41AF-88E3-87DB1E328FACQ54716857-9DAE7B6F-6F21-4D66-BB91-92F80ECF5F4B
P2860
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Beneficial association of β-bl ...... enous Inotropic Support trial.
@ast
Beneficial association of β-bl ...... enous Inotropic Support trial.
@en
type
label
Beneficial association of β-bl ...... enous Inotropic Support trial.
@ast
Beneficial association of β-bl ...... enous Inotropic Support trial.
@en
prefLabel
Beneficial association of β-bl ...... enous Inotropic Support trial.
@ast
Beneficial association of β-bl ...... enous Inotropic Support trial.
@en
P2093
P1476
Beneficial association of β-bl ...... enous Inotropic Support trial.
@en
P2093
Alain Cohen Solal
Andreas Link
Bidan Huang
Danlin Cai
Gerasimos S Filippatos
Markku S Nieminen
Matti Kivikko
Michael Böhm
Reda Salem
Robert J Padley
P304
P356
10.1097/CCM.0B013E31820A91ED
P407
P577
2011-05-01T00:00:00Z